Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/18/12 → 5/30/17 |
Funding
- UCB Pharma (domestic): $19,576.00
NO1358: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (16 to 80 years old) With Partial Onset Seizures
- Kapoor, Siddharth (PI)